The FDA authorizes Moderna and Pfizer COVID-19 boosters for all adults
SILVER SPRINGS, MD, November 19, 2021 – Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 […]
FDA authorizes boosters of Pfizer-BioNTech COVID-19 Vaccine for high risk populations
SILVER SPRING, MD, September 22, 2021 – Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in: individuals 65 years of age and older; […]
